SZY Holdings, LLC

SZY Holdings, LLC, a Brooklyn-based small business manufacturer, supplies medical equipment, consumables, and industrial goods to the Defense Logistics Agency as a prime contractor through high-volume purchase orders and indefinite delivery contracts, with all work performed at the vendor's facility in Brooklyn, New York.

SZY Holdings operates as a for-profit limited liability company competing predominantly in full-and-open federal procurements with no set-aside designations across the vast majority of its award footprint, though recent activity includes a Total Small Business single-award indefinite delivery contract and scattered Total Small Business delivery orders. The vendor's corporate structure classifies it as a manufacturer of goods. The source carries no SBA designations (8(a), HUBZone, SDVOSB, women-owned, or disadvantaged-business certifications) beyond the small business classification implicit in the Total Small Business set-aside categories on a subset of awards.

SZY's customer concentration sits entirely within the Defense Logistics Agency, which accounts for 99 percent of awards. The DLA Medical Supply Chain (Troop Support Medical) division dominates the footprint at 111,087 awards worth $103.4 million combined potential value. DLA Troop Support Construction and Equipment places 7,063 awards valued at $44.5 million, DLA Land and Maritime places 7,386 awards valued at $26.6 million, and DLA Aviation places 5,725 awards valued at $22.4 million. The rankings by count and by dollar value track closely, indicating consistent order sizing across divisions. The top five DLA divisions account for 93 percent of combined potential value.

SZY's capability footprint centers on medical consumables and equipment supply. Representative procurements include a $17,796 purchase order for impregnated gauze bandages (NSN 8512022977, Total Small Business set-aside, awarded April 8, 2026), a $19,456 order for hearing protectors from Construction and Equipment (NSN 8512042538, April 14, 2026), a $9,937.50 purchase order for leg splints from Medical Supply Chain (NSN 8512002431, April 8, 2026), a $6,916 order for wound closure kits (NSN 8512041051, April 14, 2026), a $6,222 purchase order for screw cap bottles from Construction and Equipment (NSN 8512036339, April 10, 2026), and a $4,820 order for carrying handles from Medical Supply Chain (NSN 8512036727, April 10, 2026). The portfolio spans NAICS codes for surgical instrument manufacturing (25,245 awards), surgical appliance and supplies manufacturing (23,632 awards), pharmaceutical preparation manufacturing (9,763 awards), and medical equipment wholesaling (8,243 awards). PSC category concentration reflects medical and surgical instruments (39,383 awards), drugs and biologicals (12,126 awards), hospital furniture and supplies (10,863 awards), laboratory equipment (10,151 awards), and in vitro diagnostic substances (10,107 awards).

SZY holds position on multiple DLA indefinite delivery contracts. The top vehicle by task-order count is Indefinite Delivery Contract SPE2DH20D5027 with 1,228 task orders worth $221 thousand combined potential value, followed by SPE2DH19D5006 (1,149 task orders, $142 thousand), SPE2DH18D5029 (752 task orders, $146 thousand), and SPE2DH23D5014 (713 task orders, $142 thousand). A single-award Total Small Business IDC with DLA Land and Maritime (NSN 4610134988) was awarded April 13, 2026, with a $350,000 ceiling and ultimate completion April 13, 2027, covering refractometers with a guaranteed minimum of 5 units annually and estimated four orders per year, consolidated at DLA Depots throughout CONUS and OCONUS.

Activity data shows sustained high volume: 12,233 awards in 2022 through 13,221 in 2024, with 2,448 awards recorded in 2026 year-to-date as of April 15. The awards footprint spans from October 2005 to the present. Combined potential value across all 137,914 awards stands at $217.5 million, with $129.3 million (59 percent) obligated. SZY subcontracts to no named parties in the source data; the vendor operates as a pure prime across its entire federal footprint. Awards reaching ultimate completion within the next twenty-four months total 39 orders with combined potential value of $130 thousand, representing minimal recompete exposure in the near term relative to the scale of the active portfolio.